Positive Regulation of Insulin Signaling by Neuraminidase 1
- Larbi Dridi1,
- Volkan Seyrantepe1,
- Anne Fougerat1,
- Xuefang Pan1,
- Éric Bonneil2,
- Pierre Thibault2,
- Allain Moreau3,4,5,
- Grant A. Mitchell1,
- Nikolaus Heveker5,
- Christopher W. Cairo6,
- Tarik Issad7,8,
- Alexander Hinek9 and
- Alexey V. Pshezhetsky1,5,10⇑
- 1Division of Medical Genetics, Sainte-Justine University Hospital Research Center, University of Montréal, Montréal, Québec, Canada
- 2Institute of Research in Immunology and Cancer, University of Montréal, Montréal, Québec, Canada
- 3Department of Stomatology, Faculty of Dentistry, University of Montréal, Montréal, Québec, Canada
- 4Viscogliosi Laboratory in Molecular Genetics of Musculoskeletal Diseases, Sainte-Justine University Hospital Research Center, University of Montréal, Montréal, Québec, Canada
- 5Department of Biochemistry, University of Montréal, Montréal, Québec, Canada
- 6Alberta Glycomics Centre, Department of Chemistry, University of Alberta, Edmonton, Alberta, Canada
- 7Institut Cochin, Université Paris Descartes, CNRS (UMR8104), Paris, France
- 8INSERM, U1016, Paris, France
- 9Physiology and Experimental Medicine Program, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
- 10Department of Anatomy and Cell Biology, Faculty of Medicine, McGill University, Montréal, Québec, Canada
- Corresponding author: Alexey V. Pshezhetsky, .
Neuraminidases (sialidases) catalyze the removal of sialic acid residues from sialylated glycoconjugates. We now report that mammalian neuraminidase 1 (Neu1), in addition to its catabolic function in lysosomes, is transported to the cell surface where it is involved in the regulation of insulin signaling. Insulin binding to its receptor rapidly induces interaction of the receptor with Neu1, which hydrolyzes sialic acid residues in the glycan chains of the receptor and, consequently, induces its activation. Cells from sialidosis patients with a genetic deficiency of Neu1 show impairment of insulin-induced phosphorylation of downstream protein kinase AKT, and treatment of these cells with purified Neu1 restores signaling. Genetically modified mice with ∼10% of the normal Neu1 activity exposed to a high-fat diet develop hyperglycemia and insulin resistance twice as fast as their wild-type counterparts. Together, these studies identify Neu1 as a novel component of the signaling pathways of energy metabolism and glucose uptake.
This article contains Supplementary Data online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db12-1825/-/DC1.
V.S. is currently affiliated with the Department of Molecular Biology and Genetics, Faculty of Science, Izmir Institute of Technology, Gulbahce Koyu, Urla, Izmir, Turkey.
- Received December 24, 2012.
- Accepted March 19, 2013.
- © 2013 by the American Diabetes Association.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.